Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NOx content in the CSF.: A different marker profile in four neurodegenerative diseases

被引:137
作者
Boll, Marie-Catherine [1 ,2 ]
Alcaraz-Zubeldia, Mireya [1 ]
Montes, Sergio [1 ]
Rios, Camilo [1 ]
机构
[1] Natl Inst Neurol & Neurosurgery, Dept Neurochem, Mexico City 14269, DF, Mexico
[2] Natl Inst Neurol & Neurosurgery, Dept Clin Invest Neurosci, Mexico City, DF, Mexico
关键词
Parkinson's disease; Alzheimer's disease; Huntington's disease; lateral amyotrophic sclerosis; ferroxidase; ceruloplasmin; lipid peroxidation; nitric oxide; copper; cerebrospinal fluid;
D O I
10.1007/s11064-008-9610-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The understanding of oxidative damage in different neurodegenerative diseases could enhance therapeutic strategies. Our objective was to quantify lipoperoxidation and other oxidative products as well as the activity of antioxidant enzymes and cofactors in cerebrospinal fluid (CSF) samples. We recorded data from all new patients with a diagnosis of either one of the four most frequent neurodegenerative diseases: Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD) and lateral amyotrophic sclerosis (ALS). The sum of nitrites and nitrates as end products of nitric oxide (NO) were increased in the four degenerative diseases and fluorescent lipoperoxidation products in three (excepting ALS). A decreased Cu/Zn-dependent superoxide dismutase (SOD) activity characterized the four diseases. A significantly decreased ferroxidase activity was found in PD, HD and AD, agreeing with findings of iron deposition in these entities, while free copper was found to be increased in CSF and appeared to be a good biomarker of PD.
引用
收藏
页码:1717 / 1723
页数:7
相关论文
共 35 条
[1]   Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice [J].
Alcaraz-Zubeldia, M ;
Rojas, P ;
Boll, C ;
Ríos, C .
NEUROCHEMICAL RESEARCH, 2001, 26 (01) :59-64
[2]  
Alonso ME, 1997, CLIN GENET, V51, P225
[3]  
Bayer TA, 2005, J ALZHEIMERS DIS, V8, P201
[4]   Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients [J].
Boll, MC ;
Alcaraz-Zubeldia, M ;
Montes, S ;
Murillo-Bonilla, L ;
Rios, C .
NEUROCHEMICAL RESEARCH, 2003, 28 (05) :699-703
[5]   Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease [J].
Boll, MC ;
Sotelo, J ;
Otero, E ;
Alcaraz-Zubeldia, M ;
Rios, C .
NEUROSCIENCE LETTERS, 1999, 265 (03) :155-158
[6]   Mitochondria: Regulators of signal transduction by reactive oxygen and nitrogen species [J].
Brookes, PS ;
Levonen, AL ;
Shiva, S ;
Sarti, P ;
Darley-Usmar, VM .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (06) :755-764
[8]  
Brooks BR, 1996, ARCH NEUROL-CHICAGO, V53, P141
[9]   Copper and prion disease [J].
Brown, DR .
BRAIN RESEARCH BULLETIN, 2001, 55 (02) :165-173
[10]   Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis [J].
Corona, Juan C. ;
Tovar-y-Romo, Luis B. ;
Tapia, Ricardo .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (11) :1415-1428